First ‘cell rejuvenation’ therapy in humans: Can ageing finally be treated?
Life Biosciences has launched the world's first human clinical trial for partial cellular reprogramming, a therapy aimed at reversing aspects of aging. The treatment, known as ER-100, builds on Shinya Yamanaka's research into cellular rejuvenation.
Why it matters
This represents a potential paradigm shift in medicine, moving from treating age-related diseases to addressing the biological process of aging itself.
Revolutionary Cell Rejuvenation Therapy in Humans: The Future of Aging Treatment | - The Times of India
The report focuses on scientific developments and clinical trial milestones without taking a stance on the ethics or feasibility of the treatment.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in